Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience
Background: Patients with inflammatory bowel disease (IBD) are at a higher risk of cytomegalovirus (CMV) colitis because of their immunocompromised status. There are no studies from Saudi Arabia regarding the prevalence of CMV colitis in patients with IBD. Objective: To determine the prevalence, cha...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Saudi Journal of Medicine and Medical Sciences |
Subjects: | |
Online Access: | http://www.sjmms.net/article.asp?issn=1658-631X;year=2023;volume=11;issue=4;spage=305;epage=313;aulast=Alotaibi |
_version_ | 1797226169759694848 |
---|---|
author | Yazeed Alotaibi Abed AlLehibi Abdullah Almtawa Nawaf Alotaibi Adel Alghamdi Saad Alrajhi Adel AlQutub Ahmad AlEid Abdulrhman Alamr Bashaar Al Ibrahim Mohammed Alahmari Hussam Alhamidi Shameem Ahmad Fouad Alshammari Fahad Almotawa Youssef Altannir Ahmed Alghamdi |
author_facet | Yazeed Alotaibi Abed AlLehibi Abdullah Almtawa Nawaf Alotaibi Adel Alghamdi Saad Alrajhi Adel AlQutub Ahmad AlEid Abdulrhman Alamr Bashaar Al Ibrahim Mohammed Alahmari Hussam Alhamidi Shameem Ahmad Fouad Alshammari Fahad Almotawa Youssef Altannir Ahmed Alghamdi |
author_sort | Yazeed Alotaibi |
collection | DOAJ |
description | Background: Patients with inflammatory bowel disease (IBD) are at a higher risk of cytomegalovirus (CMV) colitis because of their immunocompromised status. There are no studies from Saudi Arabia regarding the prevalence of CMV colitis in patients with IBD.
Objective: To determine the prevalence, characteristics, and risk factors of CMV colitis in patients with IBD in Riyadh, Saudi Arabia.
Materials and Methods: This retrospective study included patients with a confirmed diagnosis of IBD (aged 14–75 years) who were followed up at King Fahad Medical City, a referral care center in Riyadh, between January 2016 and December 2021; patients with indeterminate colitis or incomplete medical records were excluded.
Results: A total of 341 patients with IBD were included, of which 236 (72.2%) had Crohn's disease (CD) and 105 (27.8%) had ulcerative colitis (UC). Qualitative CMV PCR was done for 192 patients (60 UC and 132 CD patients), of which 14 patients were positive for CMV colitis (7.3%), and all positive CMV colitis cases were among UC patients (23.3%). However, the hematoxylin and eosin (H and E) stain and immunohistochemistry were negative for all patients. Most patients with CMV colitis were on steroids (71.4%), had at least one flare-up (64.3%), and were on biologic treatment (71.4%). Significant predictors of CMV colitis were hemoglobin (OR: 0.7; 95% CI: 0.51–0.96), albumin (OR: 0.88; 95% CI: 0.78–0.98), and C-reactive protein (OR: 1.03; 95% CI: 1.01–1.06) levels.
Conclusion: This study found that the prevalence of CMV colitis was 7.3% among patients with IBD, and no case was diagnosed in patients with CD. In addition, as all cases diagnosed using qualitative CMV PCR were negative on H and E stain and immunohistochemistry, there is need for large-scale studies to improve the diagnosis of CMV colitis. |
first_indexed | 2024-04-24T14:20:38Z |
format | Article |
id | doaj.art-993d6dd81d28403c8b54d66e9490c59f |
institution | Directory Open Access Journal |
issn | 1658-631X |
language | English |
last_indexed | 2024-04-24T14:20:38Z |
publishDate | 2023-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Saudi Journal of Medicine and Medical Sciences |
spelling | doaj.art-993d6dd81d28403c8b54d66e9490c59f2024-04-03T06:42:58ZengWolters Kluwer Medknow PublicationsSaudi Journal of Medicine and Medical Sciences1658-631X2023-01-0111430531310.4103/sjmms.sjmms_175_23Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experienceYazeed AlotaibiAbed AlLehibiAbdullah AlmtawaNawaf AlotaibiAdel AlghamdiSaad AlrajhiAdel AlQutubAhmad AlEidAbdulrhman AlamrBashaar Al IbrahimMohammed AlahmariHussam AlhamidiShameem AhmadFouad AlshammariFahad AlmotawaYoussef AltannirAhmed AlghamdiBackground: Patients with inflammatory bowel disease (IBD) are at a higher risk of cytomegalovirus (CMV) colitis because of their immunocompromised status. There are no studies from Saudi Arabia regarding the prevalence of CMV colitis in patients with IBD. Objective: To determine the prevalence, characteristics, and risk factors of CMV colitis in patients with IBD in Riyadh, Saudi Arabia. Materials and Methods: This retrospective study included patients with a confirmed diagnosis of IBD (aged 14–75 years) who were followed up at King Fahad Medical City, a referral care center in Riyadh, between January 2016 and December 2021; patients with indeterminate colitis or incomplete medical records were excluded. Results: A total of 341 patients with IBD were included, of which 236 (72.2%) had Crohn's disease (CD) and 105 (27.8%) had ulcerative colitis (UC). Qualitative CMV PCR was done for 192 patients (60 UC and 132 CD patients), of which 14 patients were positive for CMV colitis (7.3%), and all positive CMV colitis cases were among UC patients (23.3%). However, the hematoxylin and eosin (H and E) stain and immunohistochemistry were negative for all patients. Most patients with CMV colitis were on steroids (71.4%), had at least one flare-up (64.3%), and were on biologic treatment (71.4%). Significant predictors of CMV colitis were hemoglobin (OR: 0.7; 95% CI: 0.51–0.96), albumin (OR: 0.88; 95% CI: 0.78–0.98), and C-reactive protein (OR: 1.03; 95% CI: 1.01–1.06) levels. Conclusion: This study found that the prevalence of CMV colitis was 7.3% among patients with IBD, and no case was diagnosed in patients with CD. In addition, as all cases diagnosed using qualitative CMV PCR were negative on H and E stain and immunohistochemistry, there is need for large-scale studies to improve the diagnosis of CMV colitis.http://www.sjmms.net/article.asp?issn=1658-631X;year=2023;volume=11;issue=4;spage=305;epage=313;aulast=Alotaibicrohn's diseasecytomegalovirus colitisepidemiologydiagnosisimmunocompromisedinflammatory bowel diseasesteroidsulcerative colitis |
spellingShingle | Yazeed Alotaibi Abed AlLehibi Abdullah Almtawa Nawaf Alotaibi Adel Alghamdi Saad Alrajhi Adel AlQutub Ahmad AlEid Abdulrhman Alamr Bashaar Al Ibrahim Mohammed Alahmari Hussam Alhamidi Shameem Ahmad Fouad Alshammari Fahad Almotawa Youssef Altannir Ahmed Alghamdi Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience Saudi Journal of Medicine and Medical Sciences crohn's disease cytomegalovirus colitis epidemiology diagnosis immunocompromised inflammatory bowel disease steroids ulcerative colitis |
title | Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience |
title_full | Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience |
title_fullStr | Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience |
title_full_unstemmed | Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience |
title_short | Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience |
title_sort | prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in riyadh saudi arabia a tertiary center experience |
topic | crohn's disease cytomegalovirus colitis epidemiology diagnosis immunocompromised inflammatory bowel disease steroids ulcerative colitis |
url | http://www.sjmms.net/article.asp?issn=1658-631X;year=2023;volume=11;issue=4;spage=305;epage=313;aulast=Alotaibi |
work_keys_str_mv | AT yazeedalotaibi prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT abedallehibi prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT abdullahalmtawa prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT nawafalotaibi prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT adelalghamdi prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT saadalrajhi prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT adelalqutub prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT ahmadaleid prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT abdulrhmanalamr prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT bashaaralibrahim prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT mohammedalahmari prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT hussamalhamidi prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT shameemahmad prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT fouadalshammari prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT fahadalmotawa prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT youssefaltannir prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience AT ahmedalghamdi prevalenceandriskfactorsofcytomegaloviruscolitisininflammatoryboweldiseasepatientsinriyadhsaudiarabiaatertiarycenterexperience |